DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
E•••• B••••••• I••
Life Sciences Tools & Servicesgroup grade Aon a schedule nowsponsor unattributed
Also written as: Inc. Asset Type; The E•••• Company, LLC
Principal held
at least $254,000
sum of BDC pieces, a lower bound
Fair value
$252,000
99c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
2
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Jul 7, 2028
no dated debt inside 24 months
On the tape since
Mar 31, 2022
latest Jun 30, 2026
Events
8
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $152,000 | 99c | SOFR+575 bp | Jul 7, 2028 | 1 |
| first lien delayed draw term loan first lien | at least $102,000 | 99c | SOFR+575 bp | Jul 7, 2028 | 1 |
| delayed draw term loan lien unstated exited Mar 31, 2024 | unknown | n/a | unstated | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••••• S•••••••• C••••• F••• | term loan first lien Asset T••• F•••• L••• T••• L••• R•••••••• R••• and S••••• S + 5.75% I••••••• R••• 9.50% M• | $152,000 | $151,000 99c | SOFR+575 bp |
| A•••••• S•••••••• C••••• F••• | delayed draw term loan first lien Asset T••• F•••• L••• D•••••• D••• T••• L••• R•••••••• R••• and S••••• S + 5.75% I••••••• | $102,000 | $101,000 99c | SOFR+575 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $254,000 | $252,000 | 99c | 0 |
| Mar 31, 2026 | 1 | $254,000 | $252,000 | 99c | 2 |
| Dec 31, 2025 | 1 | $252,000 | $252,000 | 100c | 2 |
| Sep 30, 2025 | 1 | $250,000 | $250,000 | 100c | 2 |
| Jun 30, 2025 | 1 | $247,000 | $245,000 | 99c | 0 |
| Mar 31, 2025 | 1 | $247,000 | $246,000 | 100c | 0 |
| Dec 31, 2024 | 1 | $247,000 | $247,000 | 100c | 0 |
| Sep 30, 2024 | 1 | $249,000 | $249,000 | 100c | 0 |
| Jun 30, 2024 | 1 | $249,000 | $249,000 | 100c | 0 |
| Mar 31, 2024 | 1 | $249,000 | $222,000 | 100c | 0 |
What changed
- Spread changed (observed)Dec 31, 2025
- Spread changed (observed)Dec 31, 2025
- Spread increasedDec 31, 2025
- Spread increasedDec 31, 2025
- PIK interest appearsSep 30, 2025
- Spread changed (observed)Sep 30, 2025
- PIK interest appearsSep 30, 2025
- Spread changed (observed)Sep 30, 2025
- PIK interest appearsSep 30, 2025
- PIK interest appearsSep 30, 2025
- Spread increasedJun 30, 2025
- Spread increasedJun 30, 2025
- Facility left every BDC scheduleMar 31, 2024
- New borrower on a BDC scheduleMar 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- E•••• B••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Life Sciences Tools & Servicesreportedas one filer wrote it